50383-087 NDC - GUAIATUSSIN AC ()

Drug Information

Product NDC: 50383-087

Proprietary Name: Guaiatussin AC

Non Proprietary Name:

Active Ingredient(s):


Administration Route(s):

Dosage Form(s):

Labeler Information

Labeler Name: Akorn Operating Company LLC
Product Type:
FDA Application Number:
Marketing Category:
Start Marketing Date:9/8/2010

Package Information

No. Package Code Package Description Billing Unit
150383-087-04118 mL in 1 BOTTLE (50383-087-04)ML
250383-087-0710 TRAY in 1 CASE (50383-087-07) / 10 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (50383-087-05)ML
350383-087-1210 TRAY in 1 CASE (50383-087-12) / 10 CUP, UNIT-DOSE in 1 TRAY / 10 mL in 1 CUP, UNIT-DOSE (50383-087-10)ML
450383-087-16473 mL in 1 BOTTLE (50383-087-16)ML

NDC Record

Field Name Field Value Definition
PRODUCT NDC50383-087The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PROPRIETARY NAMEGuaiatussin ACThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
PROPRIETARY NAME SUFFIXSugar FreeA suffix to the proprietary name, a value here should be appended to the ProprietaryName field to obtain the complete name of the product. This suffix is often used to distinguish characteristics of a product such as extended release (“XR”) or sleep aid (“PM”). Although many companies follow certain naming conventions for suffices, there is no recognized standard.
START MARKETING DATE9/8/2010This is the date that the labeler indicates was the start of its marketing of the drug product.
LABELER NAMEAkorn Operating Company LLCName of Company corresponding to the labeler code segment of the Product NDC.

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 4/12/2024